“feng-zhang” Archives

in
Entry Author Date Location
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More 03/22/19 National
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M 03/21/19 Boston
U.S. Court Affirms Broad’s CRISPR Patent; No Word of Berkeley Appeal 09/10/18 Boston
The Winners of the 2018 Xconomy Awards Are… 09/05/18 Boston
RootPath Raises $7M to Bring Cancer Cell Therapy to Solid Tumors 08/30/18 Boston
ICER, CRISPR, Biotech Activism & More: The X of the Year Finalists 08/15/18 Boston
Precision Tinkering of Cells, Genes & Microbes: The Big Idea Finalists 07/30/18 Boston
The 2018 Xconomy Awards Finalists Are… 06/28/18 Boston
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M 05/14/18 Boston
Bio Roundup: Moderna’s Billions, Cytokine Bets, Shire Acquired & More 05/11/18 National
An Inside Look at CAR-T, Gene Therapy Launches at ‘What’s Hot’ May 16 05/09/18 Boston
Save $100 Today on “What’s Hot in Boston Biotech” on May 16 05/02/18 Boston
New CRISPR Startup from Feng Zhang Revealed 04/27/18 Boston
Bio Roundup: CRISPR Tests, Parkinson’s Questions, Opioid Bills & More 04/27/18 National
Home Tests in Mind, Doudna Startup Races Rivals in CRISPR Diagnostics 04/26/18 San Francisco
Bio Roundup: CMS Backs Cancer Tests, Right to Try Passes, AbbVie Sinks 03/23/18 National
Join Feng Zhang, Eric Lander, Craig Mello & More at What’s Hot in Boston Biotech 03/19/18 Boston
CRISPR Race 2.0: Doudna and Zhang Compete on a CRISPR Diagnostic 02/15/18 Boston
CRISPR Recovery? “Furor” Briefly Snips $500M From Companies’ Values 01/12/18 Boston
CRISPR Pioneer Zhang Details New Editing System Downstream From DNA 10/25/17 Boston
Bio Roundup: RNAi’s Big Day, CAR-T For Kids, Drugs From Fungi & More 09/22/17 National
Bio Roundup: CRISPR Advances, Obamacare Lives, FDA Nods & More 08/04/17 National
Homology Med Bags $83.5M More, Fueling Push For Gene Editing Twist 08/01/17 Boston
CRISPR Pioneer Zhang Preaches Extra Caution In Human Gene Editing 07/31/17 Boston
As Its Rivals Team Up, Editas Buys Next-Gen CRISPR From Old Friends 12/19/16 Boston
Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More 08/19/16 National
Caribou Bio’s New CRISPR Patent Isn’t About Gene Editing 02/18/16 San Francisco
CRISPR: The Path to Clinical Trials 01/29/16 Boston
As Markets and Controversies Swirl, Editas Aims For $100M CRISPR IPO 01/25/16 Boston
West Coast Bio Roundup: Big Waves, Big Cash & a Deep Pre-JPM16 Breath 01/08/16 San Francisco
Page 1 of 2 next page »